- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
- Report
- March 2024
- 188 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- March 2024
- 144 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- August 2023
- 166 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- April 2023
- 111 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- July 2021
- 50 Pages
China
From €2497EUR$2,600USD£2,150GBP
- Report
- June 2018
- 16 Pages
Global
From €9605EUR$10,000USD£8,269GBP
- Drug Pipelines
- October 2020
- 51 Pages
Global
From €3362EUR$3,500USD£2,894GBP
- Report
- June 2018
- 26 Pages
Global
From €9605EUR$10,000USD£8,269GBP
- Report
- January 2024
- 80 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- January 2024
- 81 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- June 2023
- 87 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- July 2022
- 55 Pages
Global
From €3362EUR$3,500USD£2,894GBP
Atorvastatin is a drug used to treat high cholesterol and other lipid disorders. It belongs to a class of drugs known as statins, which are used to reduce the risk of cardiovascular disease. Atorvastatin works by blocking an enzyme in the liver that is responsible for producing cholesterol. This reduces the amount of cholesterol in the blood, which can help reduce the risk of heart attack and stroke. Atorvastatin is available in both generic and brand-name forms. It is typically prescribed in combination with lifestyle changes such as diet and exercise.
Atorvastatin is one of the most widely prescribed drugs for cardiovascular disease. It is used to treat a variety of conditions, including high cholesterol, coronary artery disease, and stroke. It is also used to reduce the risk of heart attack and stroke in people with diabetes.
The atorvastatin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, Merck, AstraZeneca, and Novartis. Other companies include Mylan, Teva, and Sandoz. Show Less Read more